SECsense Logo

Sonnet Biotherapeutics 8-K Report: Key Insights for Investors - February 2025

$SONN
Form 8-K
Filed on: 2025-02-19
Source
Sonnet Biotherapeutics 8-K Report: Key Insights for Investors - February 2025

Based on the provided section of the financial report, here are the key insights and important information:

  1. Entity Information:
  • Company Name: Sonnet Biotherapeutics Holdings, Inc.
  • CIK Number: 0001106838
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-35570
  • Tax ID: 20-2932652
  • Headquarters Address: 100 Overlook Center, Suite 102, Princeton, NJ 08540
  • Contact Number: (609) 375-2227
  1. Filing Type:
  • The document is an 8-K filing, which is used to report unscheduled material events or corporate changes that are important to shareholders.
  1. Filing Date:
  • The report is dated February 19, 2025.
  1. Stock Information:
  • Common Stock Par Value: $0.0001
  • Ticker Symbol: SONN
  • Exchange: NASDAQ
  1. Contextual Information:
  • The report pertains to a specific date, with both the start and end date set to February 19, 2025.
  1. Units of Measure:
  • The financial figures are reported in USD (US Dollars) and Shares.

Summary:

This section outlines an 8-K filing for Sonnet Biotherapeutics Holdings, Inc., providing essential details about the company, including its SEC identification, stock information, and relevant dates. The filing is crucial for investors as it may contain updates on significant corporate events.